المؤلفون: Steuer, CE, Papadimitrakopoulou, V, Herbst, RS, Redman, MW, Hirsch, FR, Mack, PC, Ramalingam, SS, Gandara, DR

المصدر: Clinical Pharmacology & Therapeutics; May2015, Vol. 97 Issue 5, p488-491, 4p

مصطلحات موضوعية: CLINICAL trials, SQUAMOUS cell carcinoma, CANCER treatment, NON-small-cell lung carcinoma, LUNG cancer, ADENOCARCINOMA, EPIDERMAL growth factor receptors, ANAPLASTIC lymphoma kinase, PATIENTS

المؤلفون: Saba NF; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA. nfsaba@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, USA. nfsaba@emory.edu., Steuer CE; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Ekpenyong A; Winship Cancer Institute of Emory University, Atlanta, GA, USA., McCook-Veal A; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Magliocca K; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Patel M; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Otolaryngology, Emory University, Atlanta, GA, USA., Schmitt NC; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Otolaryngology, Emory University, Atlanta, GA, USA., Stokes W; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Bates JE; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Rudra S; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Remick J; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., McDonald M; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Abousaud M; Astellas Pharma Global Development Inc., Astellas Pharma, Northbrook, USA., Tan AC; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Fadlullah MZH; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chaudhary R; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Muzaffar J; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Kirtane K; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Liu Y; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Chen GZ; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Shin DM; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Teng Y; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Chung CH; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.

المصدر: Nature medicine [Nat Med] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

المؤلفون: Lim AM; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: annette.lim@petermac.org., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France; INSERM U900 Research unit, Institut Curie, Paris, France; Paris-Saclay University, Paris, France., Hurt C; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Laskar SG; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Steuer CE; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Chow VLY; Division of Head and Neck Surgery, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pok Fu Lam, Hong Kong Special Administrative Region, China., Szturz P; Department of Oncology, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland., Henson C; Department of Radiation Oncology, Stephenson Cancer Center, University of Oklahoma, OK, USA., Day AT; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, TX, USA., Bates JE; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Lazarakis S; Health Sciences Library, Royal Melbourne Hospital, Melbourne, VIC, Australia., McDowell L; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia., Mehanna H; Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, Edgbaston, Birmingham, UK., Yom SS; Department of Radiation Oncology, University of California, San Francisco, CA, USA; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, CA, USA. Electronic address: sue.yom@ucsf.edu.

مؤلفون مشاركون: HNCIG

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Jul; Vol. 25 (7), pp. e308-e317.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Squamous Cell Carcinoma of Head and Neck*/pathology , Squamous Cell Carcinoma of Head and Neck*/mortality , Squamous Cell Carcinoma of Head and Neck*/secondary , Squamous Cell Carcinoma of Head and Neck*/therapy , Neoplasm Recurrence, Local*/pathology , Consensus* , Head and Neck Neoplasms*/pathology , Head and Neck Neoplasms*/mortality , Head and Neck Neoplasms*/therapy , Endpoint Determination*/standards, Humans ; Clinical Trials, Phase III as Topic ; Neoplasm Metastasis

المؤلفون: Saba NF; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University, Atlanta, Georgia., Wong SJ; Department of Medicine, Medical College of Wisconsin, Pleasant Prairie., Nasti T; Winship Cancer Institute, Emory University, Atlanta, Georgia.; The Emory Vaccine Center, Emory University, Atlanta, Georgia., McCook-Veal AA; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia., McDonald MW; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Stokes WA; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Anderson AM; Winship Cancer Institute, Emory University, Atlanta, Georgia., Ekpenyong A; Winship Cancer Institute, Emory University, Atlanta, Georgia., Rupji M; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia., Abousaud M; Astellas Pharma Global Development Inc, Northbrook, Illinois., Rudra S; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Bates JE; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Remick JS; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Joshi NP; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Woody NM; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Awan M; Department of Medicine, Medical College of Wisconsin, Pleasant Prairie., Geiger JL; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Shreenivas A; Department of Medicine, Medical College of Wisconsin, Pleasant Prairie., Samsa J; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio., Ward MC; Radiation Therapy Center, Atrium Health Levine Cancer Institute, Charlotte, North Carolina., Schmitt NC; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Otolaryngology, Emory University, Atlanta, Georgia., Patel MR; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Otolaryngology, Emory University, Atlanta, Georgia., Higgins KA; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Teng Y; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University, Atlanta, Georgia., Steuer CE; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University, Atlanta, Georgia., Shin DM; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University, Atlanta, Georgia., Liu Y; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia., Ahmed R; Winship Cancer Institute, Emory University, Atlanta, Georgia.; The Emory Vaccine Center, Emory University, Atlanta, Georgia., Koyfman SA; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.

المصدر: JAMA oncology [JAMA Oncol] 2024 Jul 01; Vol. 10 (7), pp. 896-904.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Nivolumab*/adverse effects , Squamous Cell Carcinoma of Head and Neck*/radiotherapy , Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/therapy , Squamous Cell Carcinoma of Head and Neck*/pathology , Squamous Cell Carcinoma of Head and Neck*/mortality , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Neoplasm Recurrence, Local*/radiotherapy , Head and Neck Neoplasms*/radiotherapy , Head and Neck Neoplasms*/pathology , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/therapy , Head and Neck Neoplasms*/mortality, Humans ; Male ; Female ; Middle Aged ; Aged ; Re-Irradiation/methods ; Re-Irradiation/adverse effects ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects ; Neoplasms, Second Primary ; Progression-Free Survival ; Adult

المؤلفون: Pamulapati S; Internal Medicine Program, Mercyhealth Graduate Medical Education Consortium, Rockford, Illinois, USA., Abousaud M; Astellas Pharma Global Development Inc., Astellas Pharma, Northbrook, Illinois, USA., Li Y; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Ekpenyong A; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Rudra S; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA., Remick JS; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA., Bates JE; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA., Stokes WA; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA., McDonald MW; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA., Schmitt NC; Department of Otolaryngology, Emory University, Atlanta, Georgia, USA., El-Deiry MW; Department of Otolaryngology, Emory University, Atlanta, Georgia, USA., Patel MR; Department of Otolaryngology, Emory University, Atlanta, Georgia, USA., Steuer CE; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Switchenko JM; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Shin DM; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Teng Y; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Hammond A; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Saba NF; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.

المصدر: Head & neck [Head Neck] 2024 May 02. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE

المؤلفون: Yu HA; Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York. Electronic address: YuH@mskcc.org., Baik C; University of Washington/Seattle Cancer Care Alliance, Seattle, USA., Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea., Johnson ML; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, USA., Hayashi H; Kindai University, Osaka., Nishio M; The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Yang JC; National Taiwan University Hospital, Taipei City., Su WC; National Cheng Kung University Hospital, Tainan, Taiwan., Gold KA; Moores Cancer Center at UC San Diego Health, San Diego., Koczywas M; City of Hope, Duarte, USA., Smit EF; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Steuer CE; Winship Cancer Institute of Emory University, Atlanta, USA., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Murakami H; Shizuoka Cancer Center, Shizuoka, Japan., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Su X; Daiichi Sankyo, Inc., Basking Ridge, USA., Sato S; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Fan PD; Daiichi Sankyo, Inc., Basking Ridge, USA., Fujimura M; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Tanaka Y; Daiichi Sankyo, Inc., Basking Ridge, USA., Patel P; Daiichi Sankyo, Inc., Basking Ridge, USA., Sternberg DW; Daiichi Sankyo, Inc., Basking Ridge, USA., Sellami D; Daiichi Sankyo, Inc., Basking Ridge, USA., Jänne PA; Dana-Farber Cancer Institute, Boston, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 May; Vol. 35 (5), pp. 437-447. Date of Electronic Publication: 2024 Feb 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial, Phase I; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Receptor, ErbB-3*/genetics , Receptor, ErbB-3*/antagonists & inhibitors , Mutation* , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects, Humans ; Female ; Middle Aged ; Male ; Aged ; Adult ; Aged, 80 and over ; Camptothecin/analogs & derivatives ; Camptothecin/therapeutic use ; Camptothecin/administration & dosage ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Broadly Neutralizing Antibodies ; Immunoconjugates/therapeutic use ; Immunoconjugates/adverse effects ; Immunoconjugates/administration & dosage

المؤلفون: McCall NS; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Janopaul-Naylor JR; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., McGinnis HS; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Kesarwala AH; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Tian S; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Stokes WA; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Shelton JW; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Steuer CE; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Carlisle JW; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Leal TA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Bradley JD; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Higgins KA; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

المصدر: Cancer [Cancer] 2023 Dec 01; Vol. 129 (23), pp. 3713-3723. Date of Electronic Publication: 2023 Jun 24.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/radiotherapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/radiotherapy , Pneumonia*, Humans ; Chemoradiotherapy/adverse effects

المؤلفون: Steuer CE; Department of Hematology-Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Hanna GJ; Dana Farber Cancer Institute, Harvard University, Cambridge, Massachusetts, USA., Viswanathan K; Department of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Bates JE; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Kaka AS; Department of Otolaryngology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Schmitt NC; Department of Otolaryngology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Ho AL; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Saba NF; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

المصدر: CA: a cancer journal for clinicians [CA Cancer J Clin] 2023 Nov-Dec; Vol. 73 (6), pp. 597-619. Date of Electronic Publication: 2023 Jul 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0370647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-4863 (Electronic) Linking ISSN: 00079235 NLM ISO Abbreviation: CA Cancer J Clin Subsets: MEDLINE

مواضيع طبية MeSH: Salivary Gland Neoplasms*/diagnosis , Salivary Gland Neoplasms*/therapy, Humans

المؤلفون: Kirtane K; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Scheel K; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Small BJ; School of Aging Studies, University of South Florida, Tampa, Florida, USA., Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA., Muzaffar J; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Kish JA; Department of Personalized Medicine, Moffitt Cancer Center, Tampa, Florida, USA., Bonomi M; Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Bhateja P; Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Steuer CE; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Chung CH; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.

المصدر: Head & neck [Head Neck] 2023 Jul; Vol. 45 (7), pp. 1761-1771. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Head and Neck Neoplasms*/therapy , Head and Neck Neoplasms*/etiology, Humans ; Squamous Cell Carcinoma of Head and Neck/therapy ; Squamous Cell Carcinoma of Head and Neck/etiology ; Immune Checkpoint Inhibitors ; Immunotherapy/adverse effects ; Patient Reported Outcome Measures

المؤلفون: Saba NF; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA. nfsaba@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, USA. nfsaba@emory.edu., Steuer CE; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Ekpenyong A; Winship Cancer Institute of Emory University, Atlanta, GA, USA., McCook-Veal A; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Magliocca K; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Patel M; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Otolaryngology, Emory University, Atlanta, GA, USA., Schmitt NC; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Otolaryngology, Emory University, Atlanta, GA, USA., Stokes W; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Bates JE; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Rudra S; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Remick J; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., McDonald M; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Abousaud M; Astellas Pharma Global Development Inc., Astellas Pharma, Northbrook, USA., Tan AC; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Fadlullah MZH; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chaudhary R; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Muzaffar J; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Kirtane K; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA., Liu Y; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Chen GZ; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Shin DM; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Teng Y; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Chung CH; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.

المصدر: Nature medicine [Nat Med] 2023 Apr; Vol. 29 (4), pp. 880-887. Date of Electronic Publication: 2023 Apr 03.

نوع المنشور: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Vascular Endothelial Growth Factor A* , Head and Neck Neoplasms*/drug therapy, Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy